INTERCEPT PHARMACEUTICALS, INC. Quarterly Costs and Expenses in USD from Q1 2011 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2011 to Q3 2023.
  • Intercept Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2023 was $93.4M, a 6.47% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2023 was $379M, a 11.3% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $354M, a 2% decline from 2021.
  • Intercept Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $361M, a 22.1% decline from 2020.
  • Intercept Pharmaceuticals, Inc. annual Costs and Expenses for 2020 was $464M, a 17.8% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $379M $93.4M +$5.68M +6.47% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $374M $90.8M +$5.72M +6.72% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $368M $99.6M +$14M +16.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $354M $95.5M +$13.2M +16% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-02
Q3 2022 $341M $87.7M +$1.53M +1.77% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $339M $85.1M +$3.48M +4.26% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $336M $85.6M -$25.4M -22.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $361M $82.3M +$38.7M +88.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $322M $86.2M -$48.5M -36% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $371M $81.6M -$47.6M -36.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $419M $111M -$45.1M -28.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $464M $43.6M -$117M -72.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 $581M $135M -$2.8M -2.04% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $584M $129M -$680K -0.52% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $584M $156M +$19.9M +14.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $564M $161M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-02
Q3 2019 $137M +$32.2M +30.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $130M +$16.6M +14.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $136M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $105M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $113M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q2 2016 $353M $83.6M +$34.3M +69.7% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $319M $128M +$86.7M +211% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $232M $89.3M +$53.8M +151% Oct 1, 2015 Dec 31, 2015 10-K 2016-02-29
Q3 2015 $178M $52.2M +$15.7M +43% Jul 1, 2015 Sep 30, 2015 10-K 2016-02-29
Q2 2015 $162M $49.3M +$26.4M +115% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $136M $41.1M +$21.2M +106% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $115M $35.6M +$21.3M +149% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 $93.6M $36.5M +$25M +217% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 $68.6M $22.9M +$14.9M +185% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 $53.8M $19.9M +$12.7M +176% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 $41.1M $14.3M +$7.34M +105% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 $33.7M $11.5M +$7.2M +167% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 $26.5M $8.02M +$2.06M +34.6% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 $24.5M $7.23M +$3.11M +75.5% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
Q4 2012 $21.4M $6.97M +$1.77M +34.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $19.6M $4.31M +$643K +17.5% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 $18.9M $5.96M +$2.55M +74.6% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $16.4M $4.12M +$763K +22.8% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $15.6M $5.2M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 $3.67M Jul 1, 2011 Sep 30, 2011 10-K 2013-04-01
Q2 2011 $3.42M Apr 1, 2011 Jun 30, 2011 10-K 2013-04-01
Q1 2011 $3.36M Jan 1, 2011 Mar 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.